May 10 - 12, 2016 | United Kingdom
The human body is colonized by a vast number of commensal organisms, collectively termed the microbiome. Importantly, dysbiosis — dyregulation of this endemic microbiome — has been implicated in a myriad of human diseases ranging from inflammatory bowel disease, to depression.
January 7 - 8, 2016
Assess the state-of-the-art in data analytics, related challenges, and proposed solutions to accelerate progress for "Big Data" technology within the fields of neuroscience, cancer, and cardiovascular disease.
Friday, December 4, 2015 | 8:30 AM - 6:00 PM
Speakers: Melissa J. Benton (University of Colorado at Colorado Springs), David Evans (The Ohio State University), Gordon Jensen (The Pennsylvania State University), Robert Martindale (Oregon Health & Science University Healthcare), Peter A. McCullough (Dallas Baylor Heart and Vascular Hospital), Gerard Mullin (Johns Hopkins Medicine), Dennis H. Sullivan (University of Arkansas), Paul Wischmeyer (University of Colorado School of Medicine)
Lean Body Mass Loss Clinical and Nutrition Interventions
Monday, November 16, 2015 | 6:30 PM - 8:30 PM
Speakers: Kiyah Duffey (Virginia Tech), Gary D. Foster (Weight Watchers International, Inc), John Glendinning (Barnard College), Rick Mattes (Purdue University)
This evening event will unpack current scientific research from multiple disciplines, regarding the effect of non-caloric sweeteners currently approved by the Food and Drug Administration for use in foods and beverages in the United States, on weight management and health.
October 28 - 29, 2015
This 2-day colloquium will explore challenges surrounding pre-approval access to investigational medicines in a series of debates featuring prominent representatives of governments, pharmaceutical companies, patient groups, NGOs, and foundations.
Organizers: Alison Bateman-House (NYU School of Medicine), Melanie Brickman Stynes (The New York Academy of Sciences), Arthur Caplan (NYU School of Medicine), Brooke Grindlinger (The New York Academy of Sciences), and Erick Tatro (The New York Academy of Sciences)
This eBriefing explores pre-approval access to investigational medicines, the prospective benefits of which may outweigh the potential risks for critically ill patients.
Speakers: Gary D. Foster (Weight Watchers International Inc.), John Glendinning (Barnard College), and Rick Mattes (Purdue University)
This eBriefing examines the current research on noncaloric sweeteners, particularly studies assessing how the compounds affect weight management and health.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents scientific achievements by winners and finalists of the 2014 Prix Galien USA, honoring excellence in pharmaceutical science.
Edited by Juan Pablo Peña-Rosas
(World Health Organization) and Maria Nieves Garcia-Casal
(Venezuelan Institute for Scientific Research), and Luz María De-Regil
This Annals volume explores the fortification of condiments and seasonings as a new approach to mitigate micronutrient deficiencies, with discussion on the global regulatory landscape, available technologies for industrial processing, factors that may affect micronutrient bioavailability, and estimates of population iodine intake.